share_log

HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target

HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target

HC Wainwright & Co.重申买入锐佳制药,维持15美元的目标价格
Benzinga ·  2023/05/03 06:31

HC Wainwright & Co. analyst Joseph Pantginis reiterates Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and maintains $15 price target.

HC Wainwright & Co. 分析师约瑟夫·潘吉尼斯重申锐佳制药(纳斯达克股票代码:RIGL)的买入,并维持15美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发